More importantly, the higher expression of SNAI1 is related to the distant metastatic relapse in patients who had taxane-resistant breast cancer (Booser dataset from ‘R2: Genomics Analysis and Visualization Platform (http://r2.amc.nl)’) (Figure 3F). Here, SNAI1 is linked to breast carcinoma.